Iradimed Co Stock Price Prediction
| IRMD Stock | USD 97.92 1.92 1.92% |
Momentum 63
Buy Extended
Oversold | Overbought |
Quarterly Earnings Growth 0.079 | EPS Estimate Next Quarter 0.465 | EPS Estimate Current Year 1.865 | EPS Estimate Next Year 2.12 | Wall Street Target Price 99 |
Using Iradimed hype-based prediction, you can estimate the value of Iradimed Co from the perspective of Iradimed response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Iradimed using Iradimed's stock options and short interest. It helps to benchmark the overall future attitude of investors towards Iradimed using crowd psychology based on the activity and movement of Iradimed's stock price.
Iradimed Short Interest
A significant increase or decrease in Iradimed's short interest from the previous month could be a good indicator of investor sentiment towards Iradimed. Short interest can provide insight into the potential direction of Iradimed stock and how bullish or bearish investors feel about the market overall.
200 Day MA 72.2496 | Short Percent 0.0483 | Short Ratio 4.75 | Shares Short Prior Month 310.2 K | 50 Day MA 95.4822 |
Iradimed Hype to Price Pattern
Investor biases related to Iradimed's public news can be used to forecast risks associated with an investment in Iradimed. The trend in average sentiment can be used to explain how an investor holding Iradimed can time the market purely based on public headlines and social activities around Iradimed Co. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Iradimed's market sentiment to its price can help taders to make decisions based on the overall investors consensus about Iradimed.
Iradimed Implied Volatility | 0.35 |
Iradimed's implied volatility exposes the market's sentiment of Iradimed Co stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Iradimed's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Iradimed stock will not fluctuate a lot when Iradimed's options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in Iradimed to buy its stock at a price that has no basis in reality. In that case, they are not buying Iradimed because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Iradimed after-hype prediction price | USD 99.85 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Prediction based on Rule 16 of the current Iradimed contract
Based on the Rule 16, the options market is currently suggesting that Iradimed Co will have an average daily up or down price movement of about 0.0219% per day over the life of the 2026-04-17 option contract. With Iradimed trading at USD 97.92, that is roughly USD 0.0214 . If you think that the market is fully incorporating Iradimed's daily price movement you should consider acquiring Iradimed Co options at the current volatility level of 0.35%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Check out Iradimed Basic Forecasting Models to cross-verify your projections. Iradimed After-Hype Price Density Analysis
As far as predicting the price of Iradimed at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Iradimed or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Iradimed, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Iradimed Estimiated After-Hype Price Volatility
In the context of predicting Iradimed's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Iradimed's historical news coverage. Iradimed's after-hype downside and upside margins for the prediction period are 98.10 and 101.60, respectively. We have considered Iradimed's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Iradimed is very steady at this time. Analysis and calculation of next after-hype price of Iradimed is based on 3 months time horizon.
Iradimed Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Iradimed is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Iradimed backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Iradimed, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.43 | 1.77 | 0.79 | 0.04 | 9 Events / Month | 7 Events / Month | In about 9 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
97.92 | 99.85 | 0.01 |
|
Iradimed Hype Timeline
Iradimed is currently traded for 97.92. The entity has historical hype elasticity of 0.79, and average elasticity to hype of competition of 0.04. Iradimed is expected to increase in value after the next headline, with the price projected to jump to 99.85 or above. The average volatility of media hype impact on the company the price is about 96.2%. The price growth on the next news is projected to be 0.01%, whereas the daily expected return is currently at 0.43%. The volatility of related hype on Iradimed is about 2011.36%, with the expected price after the next announcement by competition of 97.96. The company reported the previous year's revenue of 73.24 M. Net Income was 19.23 M with profit before overhead, payroll, taxes, and interest of 62.05 M. Given the investment horizon of 90 days the next expected press release will be in about 9 days. Check out Iradimed Basic Forecasting Models to cross-verify your projections.Iradimed Related Hype Analysis
Having access to credible news sources related to Iradimed's direct competition is more important than ever and may enhance your ability to predict Iradimed's future price movements. Getting to know how Iradimed's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Iradimed may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| INMD | InMode | (0.02) | 8 per month | 0.00 | (0.04) | 2.33 | (2.29) | 11.46 | |
| AXGN | Axogen Inc | 1.22 | 10 per month | 1.99 | 0.23 | 6.12 | (3.06) | 30.66 | |
| TNDM | Tandem Diabetes Care | (0.39) | 8 per month | 2.86 | 0.1 | 7.03 | (4.32) | 27.06 | |
| AHCO | Adapthealth Corp | (0.15) | 6 per month | 2.11 | 0.02 | 4.17 | (3.17) | 24.44 | |
| IART | Integra LifeSciences Holdings | (0.31) | 10 per month | 0.00 | (0.12) | 5.40 | (4.33) | 26.18 | |
| CTEV | Claritev | 0.61 | 8 per month | 0.00 | (0.16) | 10.44 | (13.45) | 36.36 | |
| OPK | Opko Health | 0.01 | 10 per month | 0.00 | (0.14) | 3.03 | (3.08) | 9.92 | |
| GDRX | Goodrx Holdings | 0.03 | 8 per month | 0.00 | (0.34) | 2.86 | (4.04) | 7.49 | |
| CRON | Cronos Group | (0.18) | 9 per month | 2.29 | 0.05 | 3.72 | (3.54) | 21.46 | |
| MDXG | MiMedx Group | 0.06 | 10 per month | 0.00 | (0.16) | 3.57 | (4.28) | 12.42 |
Iradimed Additional Predictive Modules
Most predictive techniques to examine Iradimed price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Iradimed using various technical indicators. When you analyze Iradimed charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Iradimed Predictive Indicators
The successful prediction of Iradimed stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Iradimed Co, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Iradimed based on analysis of Iradimed hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Iradimed's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Iradimed's related companies. | 2023 | 2024 | 2025 | 2026 (projected) | Dividend Yield | 0.0221 | 0.0196 | 0.0226 | 0.0283 | Price To Sales Ratio | 9.13 | 9.51 | 10.94 | 9.68 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| HITI | High Tide | |
| HITI | High Tide | |
| BAC | Bank of America |
Complementary Tools for Iradimed Stock analysis
When running Iradimed's price analysis, check to measure Iradimed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Iradimed is operating at the current time. Most of Iradimed's value examination focuses on studying past and present price action to predict the probability of Iradimed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Iradimed's price. Additionally, you may evaluate how the addition of Iradimed to your portfolios can decrease your overall portfolio volatility.
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |